Compare SYNX & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYNX | POM |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | | Other Specialty Stores |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 6.5M |
| IPO Year | 2023 | 2021 |
| Metric | SYNX | POM |
|---|---|---|
| Price | $0.98 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 38.9K | 17.2K |
| Earning Date | 08-28-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $0.06 |
| 52 Week High | $1.95 | $6.43 |
| Indicator | SYNX | POM |
|---|---|---|
| Relative Strength Index (RSI) | 55.83 | 58.66 |
| Support Level | $0.94 | $0.14 |
| Resistance Level | $1.09 | $1.13 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 80.01 | 84.12 |
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sells push-to-talk devices, communication controllers, and communication device cables and connectors. Geographically, it generates the majority of its revenue from Israel.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.